Stege, H. M. http://orcid.org/0000-0002-2994-7447
Haist, M.
Schultheis, S.
Fleischer, M. I.
Mohr, P.
Ugurel, S.
Terheyden, P.
Thiem, A.
Kiecker, F.
Leiter, U.
Becker, J. C.
Meissner, M.
Kleeman, J.
Pföhler, C.
Hassel, J.
Grabbe, S.
Loquai, C.
Article History
Received: 30 September 2020
Accepted: 23 March 2021
First Online: 18 April 2021
Declarations
:
: Stege H.M., Haist M., Fleischer MI, Schultheis M, Kleeman J, Pföhler C, Hassel JC, declares no conflict of interest. Mohr P declares research support from Bristol Myers Squibb, Merck Sharp & Dohme and Novartis; speakers and advisory board honoraria from Amgen, Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono, Novartis, Pierre Fabre, Roche and Sanofi, and travel support from Bristol Myers Squibb, and Merck Sharp & Dohme, Novartis, Pierre Fabre and Roche Ugurel S declares research support from Bristol Myers Squibb and Merck Serono; speakers and advisory board honoraria from Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono, Novartis and Roche, and travel support from Bristol Myers Squibb, and Merck Sharp & Dohme. Terheyden P declares speaker’s honoraria from BMS, Novartis, MSD, Pierre-Fabre, CureVac and Roche, consultant’s honoraria from BMS, Novartis, Pierre-Fabre, Merck Serono, Sanofi und Roche and travel support from BMS, Pierre-Fabre and Roche. Thiem A has received speaker’s honoraria or travel support from Amgen, Bristol Myers Squibb, Kyowa Kirin, Merck Sharp and Dohme, Novartis and Pierre Fabre outside the submitted work. Kiecker F declares AdBoards/travel support/Speakers fee from Amgen, Novartis, BMS, MSD, Roche, Sanofi. Leiter U declares Speakers and advisory board honoraria from Merck Sharp & Dohme, Novartis, Pierre Fabre, Roche, Sanofi and Sun Pharma, research support from Merck Sharp & Dohme. Meissner M declares Research support from Novartis, speakers and advisory board honoraria from Bristol Myers Squibb, Merck Sharp & Dohme, Merck Serono, Novartis. Grabbe S declares honoraria for advisory boards, oral presentations and travel expenses from Roche, Novartis, MSD, and BMS. Loquai C declares received honoraria for advisory boards and oral presentations from Amgen, MSD, Roche, BMS, Novartis, Leo, Pierre Fabre; consultant for Roche-Posay, Roche, BMS and Biontech; travel expenses from Roche, Amgen, BMS, MSD and Novartis.
: The multicenter collection of patient data was approved by the Ethics Committee of Rhineland-Palatinate (2019-14436).